NYSE:ATGE 31 October 2025 - 15 December 2025

Robust Q1 FY2026 Results: Adtalem’s earnings for the quarter ended Sept 30, 2025 impressed on many fronts. Revenue came in at $462.3 million, up 10.8% year-over-yearbusinesswire.com, while adjusted net income rose to $64.9 millionbusinesswire.com. Adjusted earnings were $1.75 per share, a 35.7% YoY jumpbusinesswire.com, handily beating the consensus estimate of ~$1.57. GAAP EPS was $1.67 vs $1.18 in the prior-year quarterbusinesswire.com. Importantly, enrollments continued to climb, with total student enrollment up 8.0% from last yearbusinesswire.com – marking Adtalem’s ninth straight quarter of growth, a rare streak in the education industry. The Chamberlain nursing program grew enrollment +2.2%, Walden University +13.6%, and the Medical & Veterinary schools +2.4%businesswire.com. Adjusted EBITDA increased to $112.0M with a solid 24.2% marginbusinesswire.com, reflecting improved operating leverage.